Skip to content

Canagliflozin Impurity 23

Canagliflozin Impurity 23

Product Description
CAT No.
ALN-C010049
CAS No.
NA
Mol. F.
C44H49FO12S2
Mol. Wt.
853
Stock
Please Inquire
Chemical Name : (3S,4R,5R,6S)-2-(4-((5-(4-Fluoro-3-(5-(2-methyl-4-((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-2-yl)benzyl)thiophen-2-yl)phenyl)thiophen-2-yl)methyl)-3-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Smiles : O[C@@H]1C(OC)(C2=CC=C(CC3=CC=C(C4=CC=C(F)C(C5=CC=C(CC6=CC=C(C7(OC)[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)C=C6C)S5)=C4)S3)C(C)=C2)O[C@@H](CO)[C@H](O)[C@H]1O
Inchi : InChI=1S/C25H27FO6S/c1-14-16(12-18-10-11-21(33-18)15-6-8-17(26)9-7-15)4-3-5-19(14)25(31-2)24(30)23(29)22(28)20(13-27)32-25/h3-11,20,22-24,27-30H,12-13H2,1-2H3/t20-,22-,23+,24-,25?/m1/s1

Development and validation of HPLC method for determination of trace level potential genotoxic hydroperoxide impurity in canagliflozin

By Gosar, Amit; Shaikh, Tabrez; Botkondle, Suresh; Mahadik, Neelam; Tole, RahulnFrom International Journal of Pharma Research and Health Sciences (2019), 7(5), 3068-3071

Bioanalytical method development and validation of canagliflozin in human plasma by liquid chromatography-tandem mass spectrometry

By Deepan, T.; Rao, M. V. Basaveswara; Dhanaraju, M. D. – From Asian Journal of Pharmaceutical and Clinical Research (2019), 12(8), 46-51

Request For Quotation